Connect with us

Hi, what are you looking for?

Uncategorized

AbbVie trims full-year profit forecast on higher R&D expenses

© Reuters. Test tubes are seen in front of a displayed Abbvie logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

(Reuters) -AbbVie Inc cut its full-year profit forecast on Thursday, citing $280 million in milestone and in-process research and development expenses during the second quarter.

The company now expects adjusted profit between $10.57 and $10.97 per share, compared with $10.72 to $11.12 it previously expected.

Analysts on average were expecting full-year earnings of $10.97 per share, according to Refinitiv IBES data.

AbbVie (NYSE:) also trimmed adjusted profit for the second quarter by $0.15 per share and expects to post adjusted profit of $2.75 to $2.85 per share.

The company is scheduled to report second-quarter results on July 27.

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

This article was written by Follow Beyond Saving is a professional in commercial real estate providing research on REITs with a focus on properties...

Videos

Watch full video on YouTube